Clinical Trial Update: Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty: [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lacosamide to reduce post-operative opioid requirements after total hip arthroplasty has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• lacosamide (Vimpat) (lacosamide)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Osteoarthritis, Rheumatoid Arthritis | Phase 2 | Status: WITHDRAWN